Back

2023 Announcements

Category
  1. Home
  2. 2023 Announcements
Showing 1-8 of 8 results
Filter
CLINUVEL
Posted by CLINUVEL
January 31, 2023
2023 Announcements Financial Regulatory
6 min read

Appendix 4C & Activity Report

Melbourne, Australia, 31 January 2023 ASX: CUV Börse Frankfurt: UR9 ADR Level...

Read More
CLINUVEL
Posted by CLINUVEL
January 27, 2023
2023 Announcements Corporate Regulatory
6 min read

Technical Note: Developing a melanocortin pipeline

CLINUVEL today announced an update on its commercial development of the analogue...

Read More
CLINUVEL
Posted by CLINUVEL
January 23, 2023
2023 Announcements Corporate Regulatory
15 min read

NEURACTHEL® manufacturing processes advance

CLINUVEL today announced an update on its commercial development of the analogue...

Read More
CLINUVEL
Posted by CLINUVEL
January 16, 2023
2023 Announcements Clinical Regulatory
6 min read

Media release: CLINUVEL Trial Results Show Drug Reduces DNA Damage

Results from a clinical trial in a genetic DNA repair disorder show...

Read More
CLINUVEL
Posted by CLINUVEL
January 16, 2023
2023 Announcements Clinical Regulatory
6 min read

Afamelanotide Reduces DNA Photodamage in Xeroderma Pigmentosum - Technical Note

Melbourne, Australia, 16 January 2023 ASX: XETRA-DAX: ADR Level 1: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
January 16, 2023
2023 Announcements Clinical Regulatory
6 min read

Afamelanotide Reduces DNA Photodamage in Xeroderma Pigmentosum

Melbourne, Australia, 16 January 2023 ASX: XETRA-DAX: ADR Level 1: CUV UR9...

Read More
CLINUVEL
Posted by CLINUVEL
January 12, 2023
2023 Announcements Corporate Newsletter
1 min read

News Kommuniqué 1

Happy New Year to all our stakeholders for 2023, a year in...

Read More
CLINUVEL
Posted by CLINUVEL
January 10, 2023
2023 Announcements Corporate Newsletter
4 min read

News Communiqué I

On behalf of the CLINUVEL team and Board, I wish all readers...

Read More